Sunshine Biopharma Inc.
Recent Filings
All 379 filings →| Form | Description | Date |
|---|---|---|
| 8-K | FORM 8-K | Mar 9, 2026 |
| DEF 14C | FORM DEF 14C | Mar 2, 2026 |
| 8-K | CURRENT REPORT | Feb 20, 2026 |
| PRE 14C | PRELIMINARY INFORMATION STATEMENT | Feb 20, 2026 |
| 8-K | CURRENT REPORT | Feb 5, 2026 |
| 8-K | FORM 8-K | Dec 12, 2025 |
| 10-Q | FORM 10-Q FOR SEP 2025 | Nov 13, 2025 |
| DEFA14A | FORM DEFA 14A | Oct 23, 2025 |
| DEF 14A | DEFINITIVE PROXY | Oct 23, 2025 |
| 8-K | CURRENT REPORT | Sep 30, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Slilaty Steve N. | Chief Executive Officer | Purchase | 100,000 @ $0.10 | 130,000 | Mar 4, 2024 |
| Slilaty Steve N. | Chief Executive Officer | Purchase | 20,000 @ $0.10 | 30,000 | Feb 8, 2024 |
| Sebaaly Camille | CFO/Secretary | Purchase | 30,000 @ $0.76 | 174,465 | Nov 30, 2022 |
| Sebaaly Camille | CFO/Secretary | Purchase | 25,000 @ $1.22 | 144,465 | Jun 3, 2022 |
| MERZOUKI ABDERRAZZAK | Chief Operating Officer | Award / Grant | 20,000,000 | 23,342,500 | Jan 6, 2021 |
| Slilaty Steve N. | Chief Executive Officer | Award / Grant | 20,000,000 | 23,343,461 | Jan 6, 2021 |
| Sebaaly Camille | CFO/Secretary | Award / Grant | 20,000,000 | 23,893,086 | Jan 6, 2021 |
| Slilaty Steve N. | Chief Executive Officer | Award / Grant | 500,000 @ $0.10 | 1,000,000 | Jun 17, 2020 |
| Slilaty Steve N. | Chief Executive Officer | Award / Grant | 1,300,000 | 3,343,461 | Dec 31, 2019 |
| Sebaaly Camille | CFO/Secretary | Award / Grant | 550,000 | 1,493,086 | Dec 19, 2019 |